To ensure patient safety and minimize potential gastrointestinal side effects like nausea or bloating, Semaglutide is always introduced at a low starting dose, typically 0.25 mg
Subcutaneous systemic injection (at home with kit): CJC-1295/Ipamorelin and BPC-157/TB-500 are injected subcutaneously into the abdomen as part of a structured cycle
Our physicians will select the right GLP-1 medication, determine your Ipamorelin dosing, manage your titration schedule, and monitor your progress through regular labs and consultations
Dehydration and low blood sugar are the most likely causes of semaglutide headaches, so staying hydrated and eating well is important
For my boob-length hair, thats a golfball-size clump
Don't jump back to your full dose without asking first